{"id":51069,"date":"2022-11-21T12:03:22","date_gmt":"2022-11-21T11:03:22","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\/"},"modified":"2022-11-21T12:03:22","modified_gmt":"2022-11-21T11:03:22","slug":"global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\/","title":{"rendered":"Global Biodefense Market Report to 2030 &#8211; Featuring Altimmune, Emergent BioSolutions, SIGA Technologies and Ichor Medical Systems Among Others &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5648733\/biodefense-market-by-product-type-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=fhk3b4&amp;utm_campaign=1778148+-+Global+Biodefense+Market+Report+to+2030+-+Featuring+Altimmune%2C+Emergent+BioSolutions%2C+SIGA+Technologies+and+Ichor+Medical+Systems+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Biodefense Market, By Product Type, By Application, By End-Use, and By Region Forecast to 2030&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221121005396\/en\/1643622\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221121005396\/en\/1643622\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global biodefense market size is expected to reach USD 32.80 Billion in 2030 and register a revenue CAGR of 8.7% over the forecast period, according to latest report.\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAltimmune Inc.\n<\/li>\n<li>\nEmergent BioSolutions Inc.\n<\/li>\n<li>\nSIGA Technologies Inc.\n<\/li>\n<li>\nIchor Medical Systems Inc.\n<\/li>\n<li>\nElusys Therapeutics Inc.\n<\/li>\n<li>\nAlnylam Pharmaceuticals Inc.\n<\/li>\n<li>\nDynavax Technologies Corporation\n<\/li>\n<li>\nOlogy Bioservices Inc.\n<\/li>\n<li>\nDynport Vaccine Company LLC\n<\/li>\n<li>\nCleveland Biolabs Inc.\n<\/li>\n<\/ul>\n<p>\nThe market growth is attributed to the increasing government initiatives to strengthen national biodefense mechanisms and the rising research and development activities for developing newer biodefense products.\n<\/p>\n<p>\nThe outbreak of the COVID-19 pandemic has led to a significant increase in the demand for biodefense products, such as vaccines, therapeutics, and diagnostics, as healthcare professionals seek to protect themselves and others from the disease. The pandemic has also highlighted the importance of investing in strong biodefense infrastructure, which is expected to drive market growth over the forecast period.\n<\/p>\n<p>\nThe North America region is expected to hold the largest share in the global biodefense market due to the presence of a large number of key players in the region and the increasing government initiatives to strengthen national biodefense mechanisms.\n<\/p>\n<p>\nFor instance, in May 2020, the U.S. Department of Health and Human Services announced an investment of USD 1.6 Billion in Operation Warp Speed, a public-private partnership aimed at accelerating the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics.\n<\/p>\n<p>\nBiodefense comprises medical countermeasures (MCM) and other actions taken to protect people from the effects of biological warfare agents or bioterrorism. Biological warfare agents are microorganisms, such as bacteria, viruses, fungi, and toxins that can be used intentionally to cause death or disease in humans, animals, or plants. Bioterrorism is the intentional release of harmful microorganisms or toxins to cause death or disease in humans, animals, or plants.\n<\/p>\n<p>\n<strong>Some Key Highlights from the Report<\/strong>\n<\/p>\n<ul>\n<li>\nAmong product type segments, anthrax vaccine segment accounted for largest revenue share in 2021 due to growing government initiatives to promote vaccination among public and military personnel. Also, with the recent outbreak of COVID-19, there is a significant demand for vaccines and therapeutics specifically for this disease. The global biodefense market is expected to grow at a CAGR of over 12% during the period of 2021-2031.\n<\/li>\n<li>\nThe U.S. government has been at the forefront of initiatives to develop and procure biodefense products. The U.S. Department of Health and Human Services (HHS) has been the largest procurer of biodefense products, with a budget of over USD 6 billion in 2020. The U.S. government has also initiated several public-private partnerships (PPPs) to develop new vaccines and therapeutics. For instance, the HHS has partnered with Merck &amp; Co., Inc. to develop a new Ebola vaccine.\n<\/li>\n<li>\nIn terms of disease type, inhalation anthrax accounted for largest revenue share in 2021 due to high mortality rate associated with the disease. According to the Centers for Disease Control and Prevention (CDC), inhalation anthrax is fatal in over 80% of cases.\n<\/li>\n<li>\nIn terms of distribution channel, online segment is expected to grow at a rapid pace during the forecast period. The online sales channel provides easy accessibility to consumers and offers a wide range of products.\n<\/li>\n<li>\nThe hospital pharmacy segment held dominant revenue share in 2020 and the trend is expected to continue during the forecast period due to the increasing number of hospital admissions for infectious diseases.\n<\/li>\n<li>\nIn terms of regions, North America held dominant revenue share in 2020 and the trend is expected to continue during the forecast period due to the growing prevalence of infectious diseases and availability of new vaccines and therapeutics.\n<\/li>\n<li>\nThe biodefense market in Europe is expected to grow at a significant pace during the forecast period. The European Commission has been supporting initiatives to develop new vaccines and therapeutics through its Horizon 2020 program. For instance, the Horizon 2020 program has supported the development of a new vaccine against Crimean-Congo hemorrhagic fever (CCHF).\n<\/li>\n<li>\nThe biodefense market in Asia Pacific is expected to grow at a significant pace during the forecast period. The growing incidence of infectious diseases, such as Zika virus and dengue, is expected to drive the demand for vaccines and therapeutics in the region. The government agencies in the region, such as the National Healthcare Group (NHC) in Singapore, have been investing in research and development of new vaccines and therapeutics.\n<\/li>\n<\/ul>\n<p>\n<strong>For this report, the author has segmented the global biodefense market based on product type, application, end-use, and region:<\/strong>\n<\/p>\n<p>\n<strong>Product Type Outlook (Revenue, USD Billion; 2019-2030)<\/strong>\n<\/p>\n<ul>\n<li>\nAnthrax Vaccine\n<\/li>\n<li>\nSmallpox Vaccine\n<\/li>\n<li>\nBotulism Vaccine\n<\/li>\n<li>\nRadiation Vaccine\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n<strong>Application Outlook (Revenue, USD Billion; 2019-2030)<\/strong>\n<\/p>\n<ul>\n<li>\nMilitary\n<\/li>\n<li>\nCivilian\n<\/li>\n<\/ul>\n<p>\n<strong>End-use Outlook (Revenue, USD Billion; 2019-2030)<\/strong>\n<\/p>\n<ul>\n<li>\nHospitals\n<\/li>\n<li>\nClinics\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n<strong>Regional Outlook (Revenue, USD Billion; 2019-2030)<\/strong>\n<\/p>\n<ul>\n<li>\nNorth America\n<\/li>\n<li>\nUS.\n<\/li>\n<li>\nCanada\n<\/li>\n<li>\nMexico\n<\/li>\n<li>\nEurope\n<\/li>\n<li>\nGermany\n<\/li>\n<li>\nU.K.\n<\/li>\n<li>\nFrance\n<\/li>\n<li>\nItaly\n<\/li>\n<li>\nSpain\n<\/li>\n<li>\nSweden\n<\/li>\n<li>\nBENELUX\n<\/li>\n<li>\nRest of Europe\n<\/li>\n<li>\nAsia-Pacific\n<\/li>\n<li>\nChina\n<\/li>\n<li>\nIndia\n<\/li>\n<li>\nJapan\n<\/li>\n<li>\nSouth Korea\n<\/li>\n<li>\nRest of APAC\n<\/li>\n<li>\nLatin America\n<\/li>\n<li>\nBrazil\n<\/li>\n<li>\nRest of LATAM\n<\/li>\n<li>\nMiddle East &amp; Africa\n<\/li>\n<li>\nSaudi Arabia\n<\/li>\n<li>\nUAE\n<\/li>\n<li>\nSouth Africa\n<\/li>\n<li>\nIsrael\n<\/li>\n<li>\nRest of MEA\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5648733\/biodefense-market-by-product-type-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=fhk3b4&amp;utm_campaign=1778148+-+Global+Biodefense+Market+Report+to+2030+-+Featuring+Altimmune%2C+Emergent+BioSolutions%2C+SIGA+Technologies+and+Ichor+Medical+Systems+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/u9nuri<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#112;&#114;&#101;&#115;&#115;&#64;res&#x65;&#x61;&#x72;&#x63;&#x68;&#x61;&#x6e;&#x64;&#109;&#97;&#114;&#107;&#101;ts&#46;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#x65;&#x73;&#x73;&#x40;&#114;&#101;&#115;&#101;arch&#x61;&#x6e;&#x64;&#x6d;&#x61;&#x72;&#107;&#101;&#116;&#115;&#46;com<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Biodefense Market, By Product Type, By Application, By End-Use, and By Region Forecast to 2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global biodefense market size is expected to reach USD 32.80 Billion in 2030 and register a revenue CAGR of 8.7% over the forecast period, according to latest report. Companies Mentioned &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51069","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Biodefense Market Report to 2030 - Featuring Altimmune, Emergent BioSolutions, SIGA Technologies and Ichor Medical Systems Among Others - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Biodefense Market Report to 2030 - Featuring Altimmune, Emergent BioSolutions, SIGA Technologies and Ichor Medical Systems Among Others - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Biodefense Market, By Product Type, By Application, By End-Use, and By Region Forecast to 2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global biodefense market size is expected to reach USD 32.80 Billion in 2030 and register a revenue CAGR of 8.7% over the forecast period, according to latest report. Companies Mentioned ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-21T11:03:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221121005396\/en\/1643622\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Biodefense Market Report to 2030 &#8211; Featuring Altimmune, Emergent BioSolutions, SIGA Technologies and Ichor Medical Systems Among Others &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-11-21T11:03:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\\\/\"},\"wordCount\":910,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221121005396\\\/en\\\/1643622\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\\\/\",\"name\":\"Global Biodefense Market Report to 2030 - Featuring Altimmune, Emergent BioSolutions, SIGA Technologies and Ichor Medical Systems Among Others - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221121005396\\\/en\\\/1643622\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-11-21T11:03:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221121005396\\\/en\\\/1643622\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221121005396\\\/en\\\/1643622\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Biodefense Market Report to 2030 &#8211; Featuring Altimmune, Emergent BioSolutions, SIGA Technologies and Ichor Medical Systems Among Others &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Biodefense Market Report to 2030 - Featuring Altimmune, Emergent BioSolutions, SIGA Technologies and Ichor Medical Systems Among Others - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Biodefense Market Report to 2030 - Featuring Altimmune, Emergent BioSolutions, SIGA Technologies and Ichor Medical Systems Among Others - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Biodefense Market, By Product Type, By Application, By End-Use, and By Region Forecast to 2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global biodefense market size is expected to reach USD 32.80 Billion in 2030 and register a revenue CAGR of 8.7% over the forecast period, according to latest report. Companies Mentioned ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-21T11:03:22+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221121005396\/en\/1643622\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Biodefense Market Report to 2030 &#8211; Featuring Altimmune, Emergent BioSolutions, SIGA Technologies and Ichor Medical Systems Among Others &#8211; ResearchAndMarkets.com","datePublished":"2022-11-21T11:03:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\/"},"wordCount":910,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221121005396\/en\/1643622\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\/","name":"Global Biodefense Market Report to 2030 - Featuring Altimmune, Emergent BioSolutions, SIGA Technologies and Ichor Medical Systems Among Others - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221121005396\/en\/1643622\/21\/logo.jpg","datePublished":"2022-11-21T11:03:22+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221121005396\/en\/1643622\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221121005396\/en\/1643622\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Biodefense Market Report to 2030 &#8211; Featuring Altimmune, Emergent BioSolutions, SIGA Technologies and Ichor Medical Systems Among Others &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51069","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51069"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51069\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51069"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51069"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51069"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}